MiNK Therapeutics, Inc.
INKT
$11.71
-$0.48-3.90%
NASDAQ
| 09/30/2025 | 06/30/2025 | 03/31/2025 | 12/31/2024 | 09/30/2024 | |
|---|---|---|---|---|---|
| Total Cash And Short-Term Investments | 14.28M | 1.68M | 3.23M | 4.58M | 6.33M |
| Total Receivables | -- | -- | -- | -- | -- |
| Inventory | -- | -- | -- | -- | -- |
| Prepaid Expenses | 253.10K | 274.10K | 236.20K | 246.60K | 235.80K |
| Finance Division Loans and Leases Current | -- | -- | -- | -- | -- |
| Total Finance Division Other Current Assets | -- | -- | -- | -- | -- |
| Other Current Assets | 0.00 | 55.20K | 108.70K | 164.20K | 11.20K |
| Total Current Assets | 14.53M | 2.01M | 3.58M | 4.99M | 6.58M |
|
|
|||||
| Total Current Assets | 14.53M | 2.01M | 3.58M | 4.99M | 6.58M |
| Net Property, Plant & Equipment | 429.30K | 473.20K | 687.50K | 732.90K | 799.50K |
| Long-term Investments | -- | -- | -- | -- | -- |
| Goodwill | -- | -- | -- | -- | -- |
| Total Other Intangibles | -- | -- | -- | -- | -- |
| Finance Div Loans & Leases LT | -- | -- | -- | -- | -- |
| Total Finance Div Other LT Assets | -- | -- | -- | -- | -- |
| Total Other Assets | -- | -- | -- | -- | -- |
| Total Assets | 14.96M | 2.48M | 4.27M | 5.72M | 7.37M |
|
|
|||||
| Total Accounts Payable | 3.69M | 3.31M | 2.66M | 2.73M | 2.36M |
| Total Accrued Expenses | 1.26M | 1.86M | 1.97M | 1.87M | 2.65M |
| Short-term Debt | -- | -- | -- | -- | -- |
| Current Portion of Long-Term Debt/Capital Leases | -- | -- | -- | -- | -- |
| Finance Division Debt Current | 5.73M | 5.51M | 5.12M | -- | -- |
| Total Finance Division Other Current Liabilities | 2.76M | 2.48M | 2.37M | 2.36M | 2.39M |
| Total Other Current Liabilities | 2.76M | 2.48M | 2.37M | 2.36M | 2.39M |
| Total Current Liabilities | 13.43M | 13.16M | 12.12M | 6.96M | 7.40M |
|
|
|||||
| Total Current Liabilities | 13.43M | 13.16M | 12.12M | 6.96M | 7.40M |
| Long-Term Debt | -- | -- | -- | 4.92M | 4.61M |
| Short-term Debt | -- | -- | -- | -- | -- |
| Capital Leases | -- | -- | -- | -- | -- |
| Finance Division Debt Non Current | -- | -- | -- | -- | -- |
| Total Finance Division Other Non Current Liabilities | -- | -- | -- | -- | -- |
| Total Other Liabilities | 15.04M | 14.51M | 13.94M | 13.42M | 12.92M |
| Total Liabilities | 28.48M | 27.67M | 26.06M | 25.31M | 24.93M |
|
|
|||||
| Common Stock & APIC | 141.25M | 126.72M | 125.82M | 125.23M | 124.84M |
| Retained Earnings | -154.07M | -151.19M | -146.95M | -144.18M | -141.72M |
| Treasury Stock & Other | -692.10K | -719.30K | -662.40K | -631.60K | -672.80K |
| Total Common Equity | -13.51M | -25.19M | -21.79M | -19.59M | -17.55M |
|
|
|||||
| Preferred Stock Redeemable | -- | -- | -- | -- | -- |
| Preferred Stock Non Redeemable | -- | -- | -- | -- | -- |
| Preferred Stock Convertible | -- | -- | -- | -- | -- |
| Preferred Stock, Others | -- | -- | -- | -- | -- |
| Total Preferred Equity | -- | -- | -- | -- | -- |
|
|
|||||
| Total Common Equity | -13.51M | -25.19M | -21.79M | -19.59M | -17.55M |
| Total Preferred Equity | -- | -- | -- | -- | -- |
| Total Minority Interest | -- | -- | -- | -- | -- |
| Total Equity | -13.51M | -25.19M | -21.79M | -19.59M | -17.55M |
|
|
|||||